Siegfried Holding AG (XSWX:SFZN) Receivables Turnover: 2.03 (As of Dec. 2025)


XSWX:SFZN Siegfried Holding AG XSWX:SFZN
93 GF Score
Price CHF72.50
GF Value CHF92.31
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Siegfried Holding AG Receivables Turnover?

Siegfried Holding AG XSWX:SFZN +0.07% 93 Receivables Turnover is 2.03 as of Dec. 2025. GuruFocus rates XSWX:SFZN with a GF Score™ of 93/100 and a GF Value™ of CHF92.31 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 950 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 71.26% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Siegfried Holding AG's Revenue for the six months ended in Dec. 2025 was CHF708 Mil. Siegfried Holding AG's average Accounts Receivable for the six months ended in Dec. 2025 was CHF349 Mil. Hence, Siegfried Holding AG's Receivables Turnover for the six months ended in Dec. 2025 was 2.03.


Siegfried Holding AG  (XSWX:SFZN) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Siegfried Holding AG Receivables Turnover Related Terms


Siegfried Holding AG Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Siegfried Holding AG's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siegfried Holding AG Receivables Turnover Chart

Siegfried Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.21 4.07 3.71 3.49 3.38

Siegfried Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 1.89 1.92 1.77 2.03

XSWX:SFZN vs ZTS, UTHR, VTRS: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's Receivables Turnover falls into.


XSWX:SFZN
93GF Score
Siegfried Holding AG XSWX:SFZN
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siegfried Holding AG Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Siegfried Holding AG's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=1327.834 / ((395.008 + 391.69) / 2 )
=1327.834 / 393.349
=3.38

Siegfried Holding AG's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=708.317 / ((306.831 + 391.69) / 2 )
=708.317 / 349.2605
=2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 2.03 mean?
Siegfried Holding AG (XSWX:SFZN) has a Receivables Turnover of 2.03 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Siegfried Holding AG and its competitors. According to the industry distribution chart, Siegfried Holding AG ranks #677 out of 950 companies in the Drug Manufacturers industry, placing it in the top 71.3%.
Is Siegfried Holding AG's Receivables Turnover too high?
Siegfried Holding AG's current Receivables Turnover is 2.03. The Drug Manufacturers industry median Receivables Turnover is 5.07. Siegfried Holding AG's value of 2.03 is 60% below this industry median. Based on the distribution chart, Siegfried Holding AG ranks #677 out of 950 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #677 out of 950 companies for Receivables Turnover. This places Siegfried Holding AG in the lower half of its industry. The industry median Receivables Turnover is 5.07. Siegfried Holding AG's value of 2.03 is 60% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current Receivables Turnover of 2.03 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current Receivables Turnover is 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF92.31, compared to a current price of CHF72.50 — trading 21.5% below its estimated fair value. The current Receivables Turnover is 2.03 and 60% below the Drug Manufacturers industry median of 5.07. Siegfried Holding AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current Receivables Turnover is 2.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?

Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued. The current stock price of CHF72.50 is trading 21.5% below its estimated GF Value™ of CHF92.31. GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:SFZN:

  • Receivables Turnover: 2.03
  • GF Value™: CHF92.31 vs. price of CHF72.50 (21.5% below fair value)
  • GF Score™: 93/100 with 2 warning signs
  • Industry Position: 60% below the Drug Manufacturers median (#677 of 950)

No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siegfried Holding AG Business Description

Address Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
93GF Score

Get the complete analysis for XSWX:SFZN

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF72.50
Price
CHF92.31
GF Value